
Fluticasone propionate CAS NO.80474-14-2
We are a manufacturer based in China. We specialize in providing high-quality Fluticasone propionate CAS NO.80474-14-2 for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.
Category:Active Pharmaceutical Ingredients Own Brand:MT /MOQ:100KG /From China/ B2B only.
Introduction
Catalog ID80017765
CAS NO.80474-14-2
Purity 95+%
MDL NumberMFCD00866007
EINEC Molecular Formula C25H31F3O5S
Molecular Weight 500.5708
Melting point 272~273°C
| Aspect | Details |
|---|---|
| Mechanism of Action | Fluticasone propionate is a potent corticosteroid that exerts its effects by binding to glucocorticoid receptors. It reduces inflammation by inhibiting the production of inflammatory mediators such as cytokines and leukotrienes. It also decreases the number of inflammatory cells (e.g., eosinophils, mast cells) and increases the expression of anti-inflammatory proteins. |
| Pharmacokinetics | – Absorption: Systemic bioavailability is low after oral inhalation (<1%) and intranasal use (<2%). Most of the inhaled dose is swallowed and undergoes extensive first-pass metabolism.<br>- Distribution: Highly protein-bound (99%) in serum. Volume of distribution is 4.2 L/kg.<br>- Metabolism: Extensively metabolized in the liver by cytochrome P450 3A4 (CYP3A4), forming inactive metabolites.<br>- Excretion: Primarily eliminated via feces, with <5% excreted in urine.<br>- Half-Life: Terminal half-life is approximately 7.8 to 10.8 hours. |
| Safety Profile | – Systemic Effects: Low risk of systemic side effects such as hypothalamic-pituitary-adrenal (HPA) axis suppression due to low systemic absorption.<br>- Local Effects: May cause local side effects such as oral thrush or skin atrophy with prolonged topical use.<br>- Special Populations: Caution advised in patients with liver impairment due to the drug’s extensive hepatic metabolism. |
| Administration | – Inhalation: Available as metered-dose inhalers (MDIs) and dry powder inhalers (DPIs).<br>- Topical: Available as creams and ointments for dermatological use.<br>- Nasal: Available as nasal sprays for allergic rhinitis. |
| Indications | Used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and various skin conditions. |
| Storage Conditions | Store at room temperature (15° to 30°C; 59° to 86°F). Protect from moisture and light. |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.



